Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Roche reports positive studies of MabThera given by subcutaneous injection
Teaching NeuroImages: MRI in advanced neuromyelitis optica.
Immunologic monitoring during a phase 2a trial of the GNbAC1 antibody in patients with MS.
New data analyses show significant clinical and MRI improvements with PLEGRIDY™ (peginterferon beta-1a)
Population Pharmacokinetics of Daclizumab High-Yield Process in Healthy Volunteers and Subjects with Multiple Sclerosis: Analysis of Phase I-III Clinical Trials.
[Nicolau syndrome after administration of glatiramer acetate].
Oral Laquinimod for Multiple Sclerosis Granted Fast Track Status by FDA
Involvement of AMPK, IKβα-NFκB and eNOS in the sildenafil anti-inflammatory mechanism in a demyelination model.
First patient treated in Mapi Pharma's Phase IIa clinical trial of GA Depot for relapsing remitting multiple sclerosis (RRMS)
Roche's MabThera approved for two vasculitis indications in UK
Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma
UPDATE 1-Teva Pharmaceutical banks on thrice-weekly Copaxone
Copolymer-1 induces adaptive immune anti-inflammatory glial and neuroprotective responses in a murine model of HIV-1 encephalitis.
Testing for urinary tract colonisation before high-dose corticosteroid treatment in acute multiple sclerosis relapses: prospective algorithm validation.
Rituximab Use in Pediatric Central Demyelinating Disease.
The effect of vitamin a supplementation on biochemical parameters in multiple sclerosis patients.
Altered likelihood of brain activation in attention and working memory networks in patients with multiple sclerosis: An ALE meta-analysis.
Company restores access to multiple sclerosis drug after pressure from neurologists.
Laquinimod in multiple sclerosis.
Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE.
Predictive value of early brain atrophy on response in patients treated with interferon β.
Neuroprotective effect of masitinib in rats with postischemic stroke.
PI(3,5)P2 biosynthesis regulates oligodendrocyte differentiation by intrinsic and extrinsic mechanisms.
FTY720 in patients with primary progressive multiple sclerosis (INFORMS)
Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of β-Amyloid in TH1 and TH17 Versions of Experimental Autoimmune Encephalomyelitis.

Pages